Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
10,876,096
-
Total 13F shares
-
1,724,718
-
Share change
-
+20,598
-
Total reported value
-
$4,655,967
-
Price per share
-
$2.70
-
Number of holders
-
20
-
Value change
-
+$78,103
-
Number of buys
-
9
-
Number of sells
-
7
Institutional Holders of AYTU BIOPHARMA, INC - Common Stock (AYTU) as of Q3 2023
As of 30 Sep 2023 AYTU BIOPHARMA, INC - Common Stock (AYTU) had 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,724,718 shares of stock of the company.
Largest 10 holders included Nantahala Capital Management, LLC, Stonepine Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, VANGUARD GROUP INC, Tower Research Capital LLC (TRC), and UBS Group AG.
This table shows 20 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.